Sensei Biotherapeutics Inc (SNSE)
1.52
-0.07
(-4.40%)
USD |
NASDAQ |
May 17, 16:00
1.52
0.00 (0.00%)
After-Hours: 20:00
Sensei Biotherapeutics Total Liabilities (Quarterly): 8.221M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 8.221M |
| December 31, 2023 | 9.479M |
| September 30, 2023 | 10.66M |
| June 30, 2023 | 10.38M |
| March 31, 2023 | 13.08M |
| December 31, 2022 | 14.97M |
| September 30, 2022 | 14.82M |
| June 30, 2022 | 12.12M |
| Date | Value |
|---|---|
| March 31, 2022 | 14.73M |
| December 31, 2021 | 6.712M |
| September 30, 2021 | 6.041M |
| June 30, 2021 | 4.599M |
| March 31, 2021 | 3.224M |
| December 31, 2020 | 77.87M |
| September 30, 2020 | 57.20M |
| December 31, 2019 | 69.88M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.224M
Minimum
Mar 2021
77.87M
Maximum
Dec 2020
20.87M
Average
11.39M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 66.70M |
| Shareholders Equity (Quarterly) | 58.47M |